Blood Res 2018; 53(2): 103
Splenic marginal zone lymphoma relapsing as miliary lung mottling: an unusual presentation
Tanmoy Mandal, Anuj Verma, Vikas Talreja, Sangeetha Kamrajpuram Parthiban, Anant Gokarn, Hasmukh Jain, Bhausaheb Bagal*, Sandeep Tandon, Manju Sengar, and Tanuja Shet

Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Mumbai, India.

Correspondence to: Bhausaheb Bagal, M.D., Department of Medical Oncology, Tata Memorial Center, Homi Bhabha National Institute, Dr. E Borges Road, Parel, Mumbai, Maharashtra 400012, India.
Received: September 10, 2017; Revised: September 30, 2017; Accepted: November 1, 2017; Published online: June 25, 2018.
© The Korean Journal of Hematology. All rights reserved.



A 52-year-old man presented in October 2016 with a 3-week history of easy fatigability, intermittent fever, cough, and dyspnea. He was diagnosed with hepatitis C virus-negative splenic marginal zone lymphoma (SMZL) in 2008 and had undergone splenectomy. Physical examination revealed mild hepatomegaly without lymphadenopathy, and the chest was clear on auscultation. Laboratory tests were unremarkable, except for mild anemia. Chest computed tomography (CT) was performed on suspecting relapse, which revealed multiple pulmonary nodules (A). Considering miliary mottling, he underwent evaluations for tuberculosis. His Mantoux test results were negative and bronchoalveolar lavage fluid did not show acid-fast bacilli. Polymerase chain reaction for tuberculosis and Mycobacterium growth culture were also negative. CT-guided biopsy of the lung nodules showed non-Hodgkin's lymphoma (C). The MIB-1 labeling index was 50–60% (D). The tumor cells were positive for cluster of differentiation (CD)20 (E) and negative for CD10 (F) and Bcl2, consistent with lung involvement as marginal zone lymphoma. He was administered rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone; after 4 cycles, chest CT revealed complete response (B). Our case highlights an unusual SMZL relapse pattern after splenectomy, emphasizing the need for re-biopsy in patients with rare lymphoma presentations.


This Article

Current Issue


Indexed/Covered by

Today : 111  /
Total : 170,111